Understanding Human Papillomavirus Vaccine Promotions and Hesitancy in Northern California Through Examining Public Facebook Pages and Groups.
Facebook
HPV vaccine
Northern California
sentiment analysis
social media
topic modeling
vaccine hesitancy
Journal
Frontiers in digital health
ISSN: 2673-253X
Titre abrégé: Front Digit Health
Pays: Switzerland
ID NLM: 101771889
Informations de publication
Date de publication:
2021
2021
Historique:
received:
19
03
2021
accepted:
25
05
2021
entrez:
29
10
2021
pubmed:
30
10
2021
medline:
30
10
2021
Statut:
epublish
Résumé
Human papillomavirus (HPV) vaccination coverage among adolescents is lower in rural regions and remains under the 80% coverage goal by Healthy People 2030. Through both sentiment analysis and topic modeling, this research examines how local health agencies and groups in nine Northern California counties promote HPV vaccines through Facebook and how target populations react to promotion posts in comments that elucidate their sentiments and hesitancy toward HPV vaccination. In January 2021, we identified 2,105 public Facebook pages and 1,065 groups related to health within the counties and collected a total of 212 posts and 505 comments related to the HPV vaccine. The posts were published between 2010 and 2021, with the majority (83%) published after 2017. There were large variations of Facebook activities across counties. We categorized four counties with HPV vaccination initiation rates below 40% as low-coverage counties and five counties with rates above 40% as high-coverage counties. In general, low-coverage counties had fewer Facebook activities in comparison to high coverage. Results showed that, on average, comments about the HPV vaccine exhibited more positive emotion, more negative emotion, and more anger than the posts. Overall, thematic topics that emerged from posts centered around awareness and screening of HPV and cervical cancer, STI testing services, information sources, and calls to action for health services. However, comment topics did not correspond to posts and were mostly related to vaccine hesitancy, discussing vaccine risks, safety concerns, and distrust in vaccine science, citing misinformation. When comparing high- versus low-coverage counties, posts expressed similar sentiments; however, comments within high-coverage counties expressed more anger than in low-coverage counties. Comments from both high- and low-coverage counties expressed concerns with vaccine safety, risks, and injury. It is important to note that commenters exchanged information sources and tried to address misinformation themselves. Our results suggest that the promotion of HPV vaccines from public Facebook pages and groups is limited in frequency and content diversity. This illustrates problems with generalized social media vaccination promotion without community tailoring and addressing specific hesitancy concerns. Public health agencies should listen to the thoughts of targeted audiences reflected through comments and design relevant messages to address these concerns for HPV vaccination promotion.
Identifiants
pubmed: 34713153
doi: 10.3389/fdgth.2021.683090
pmc: PMC8521881
doi:
Types de publication
Journal Article
Langues
eng
Pagination
683090Informations de copyright
Copyright © 2021 Zhang, Xue, Calabrese, Chen and Dang.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
JAMA Pediatr. 2014 Jan;168(1):76-82
pubmed: 24276343
J Med Internet Res. 2016 Aug 29;18(8):e232
pubmed: 27573910
PLoS One. 2019 Feb 11;14(2):e0211931
pubmed: 30742683
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Vaccine. 2020 Jun 26;38(31):4909-4915
pubmed: 32482460
Lancet Child Adolesc Health. 2018 Oct;2(10):707-714
pubmed: 30236379
Vaccine. 2016 Nov 11;34(47):5808-5814
pubmed: 27707558
Prev Med. 2020 Feb;131:105968
pubmed: 31881235
J Commun. 2019 Jun;69(3):298-319
pubmed: 31205334
J Health Commun. 2020 Feb 1;25(2):159-169
pubmed: 32026756
Vaccine. 2020 Jun 15;38(29):4564-4573
pubmed: 32417141
Hum Vaccin Immunother. 2019;15(7-8):1496-1504
pubmed: 31194609
Health Educ Behav. 2019 Dec;46(2_suppl):37-48
pubmed: 31742459
MMWR Morb Mortal Wkly Rep. 2016 Dec 16;65(49):1405-1408
pubmed: 27977643
J Health Commun. 2020 Sep 1;25(9):692-702
pubmed: 33103600
Prev Med. 2019 Sep;126:105751
pubmed: 31226342
MMWR Morb Mortal Wkly Rep. 2019 Aug 23;68(33):718-723
pubmed: 31437143
Nature. 2020 Jun;582(7811):230-233
pubmed: 32499650
NCHS Data Brief. 2020 Jan;(354):1-8
pubmed: 32487295
Prev Med. 2021 Apr;145:106408
pubmed: 33388335
MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1109-1116
pubmed: 32817598
J Cancer Educ. 2019 Aug;34(4):819-822
pubmed: 29948924
Health Commun. 2012;27(8):829-36
pubmed: 22452582
J Am Med Inform Assoc. 2020 Feb 1;27(2):225-235
pubmed: 31711186
J Med Internet Res. 2021 Jan 5;23(1):e23262
pubmed: 33399543
Am J Public Health. 2016 Dec;106(12):2211-2218
pubmed: 27736208
J Rural Health. 2019 Sep;35(4):506-517
pubmed: 30703854
Vaccine. 2017 May 25;35(23):3033-3040
pubmed: 28461067
MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):698-702
pubmed: 31415491
Health Commun. 2020 May;35(5):607-615
pubmed: 31199698
J Med Internet Res. 2016 Dec 05;18(12):e318
pubmed: 27919863
J Med Internet Res. 2020 Dec 3;22(12):e21451
pubmed: 33270038